Exercise of Warrants

AI SummaryClose X

ImmuPharma PLC announced the exercise of 2,500,000 warrants over new ordinary shares at 5p per share, resulting in a consideration of £125,000. These new ordinary shares, representing 0.50% of the company's enlarged issued share capital, have been allotted and will rank equally with existing shares. Application has been made for these shares to be admitted to trading on the AIM market, with admission expected around September 16, 2025. Following admission, the company's total issued share capital will consist of 502,223,932 ordinary shares with a nominal value of 1p each.

Disclaimer*

Companies

Immupharma (IMM)
UK 100

Latest directors dealings